EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2017
CVR: 32770487
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,507,395 and a net result of DKK -5,131,946 compared with DKK -7,120,464 the year before. Equity in the 2017 report amounted to DKK -4,581,393. The company had 11 employees in the financial year.
- Gross Profit
- DKK 2,507,395
- Profit/Loss
- DKK -5,131,946
- Equity
- DKK -4,581,393
- Total Assets
- DKK 5,095,293
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.5 mio. | -5.1 mio. | -4.6 mio. | 11 |
| 2016 | - | -494 t. | -7.1 mio. | 551 t. | 9 |
| 2015 | - | -2.2 mio. | -6.7 mio. | -4.9 mio. | - |
| 2014 | - | 5.3 mio. | 226 t. | 1.8 mio. | - |
| 2013 | - | 5.7 mio. | 585 t. | 1.6 mio. | - |
Official annual report
Keep an eye on EXPRES2ION BIOTECHNOLOGIES ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2016. Gross profit came to DKK -493,626, and the net result was DKK -7,120,464.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.